Playground myths about sex are misleading teenagers. According to a recent survey conducted by Department for Children, Schools and Families on 500 children aged 11 to 14, most of the children had misconceptions about sex. 

The most popular among theses misconceptions include – that first time sex does not make you pregnant, it is unhealthy for a boy with an erection not to have sex, condoms can be re used after washing, you cannot get pregnant standing up and tampons make you lose virginity. 

Farmers are being criticized for an outbreak of the deadly bluetongue virus, among cattle in North Wales this week. There are confirmed reports, of two cases of BTV8 strain of bluetongue at a farm near Ruthin, on Tuesday. 

Bluetongue is characterised by changes in the mucous linings of the mouth and nose, and the coronary band of the foot, but it is not harmful to humans at all. 

Although vaccination for BTV8 is available, but BTV1 has no vaccination and can prove fatal. 

The Health Minister Vishwajit Rane inaugurated ‘The Clinic on Wheels’ for the diabetics in the state. These clinics will be equipped with all state of the art facilities to detect diabetes and offer treatment along with educational material to offer to spread awareness about the effects of the disease and how early diagnosis of high sugar levels can prevent complications at a later stage. 

A recent study by the researchers at University of the West of England has shown that an accommodation in a bustling locality can lead to “fewer friends”. This study was led by Joshua Hart of the University of the West of England, Bristol. This study supports result of the previous study that showed that the weight of traffic beside a person's home can determine their quality of life.  

A clinical trial of Amgen’s experimental bone drug on 7,800 postmenopausal women with osteoporosis showed a 68% reduction in the risk of spinal fractures in women with osteoporosis. Denosumab has been found to also reduce the risk of hip fractures by 40% and the risk of all non-spinal fractures by 20%. 

The results of a short term trial comparing experimental drug Ustekinumab with existing Enbrel carried out on 902-patients and presented at the European Academy of Dermatology and Venereology Congress in Paris, indicate the superiority of Ustekinumab over Enbrel in treating moderate to severe plaque psoriasis. 

The 12-week trial saw one group of patients given one short of Ustekinumab at the start with a booster shot four weeks later, while other patients received two shots of Enbrel each week.